Published in Epidemiol Rev on January 01, 1984
Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ (1990) 6.70
Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey. BMJ (1989) 3.74
Capitalizing on Mendelian randomization to assess the effects of treatments. J R Soc Med (2007) 1.66
Serum cholesterol and primary brain tumours: a case-control study. Br J Cancer (1985) 1.20
Plasma cholesterol concentration and primary brain tumours. BMJ (1989) 1.09
Coffee, cholesterol, and colon cancer: is there a link. Br Med J (Clin Res Ed) (1987) 0.85
Changes in serum lipids related to the presence of experimental colon cancer. Br J Cancer (1987) 0.83
Insulin-tumour interrelationship in EL4 lymphoma or thymoma-bearing mice. I. Alloxan-diabetic or non-diabetic mice. Br J Cancer (1990) 0.79
Insulin-tumour interrelationships in EL4-lymphoma or thymoma-bearing mice. II. Effects of dietary omega-3 and omega-6 polyunsaturated fatty acids. Br J Cancer (1990) 0.78
Phenotypic analysis of antigen-specific T lymphocytes. Science (1996) 24.26
The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell (1986) 14.96
Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med (1997) 12.26
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science (1998) 12.05
Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer (2010) 10.61
Common west African HLA antigens are associated with protection from severe malaria. Nature (1991) 9.43
Cytotoxic T-cell immunity to influenza. N Engl J Med (1983) 8.49
Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature (2001) 7.90
Bias due to misclassification in the estimation of relative risk. Am J Epidemiol (1977) 7.28
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature (1998) 7.12
Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med (2001) 6.51
Standardized mortality ratios and the "healthy worker effect": Scratching beneath the surface. J Occup Med (1976) 6.40
Rapid effector function in CD8+ memory T cells. J Exp Med (1997) 6.36
Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer (1999) 6.11
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med (2000) 5.79
Environmental exposure to lead and children's intelligence at the age of seven years. The Port Pirie Cohort Study. N Engl J Med (1992) 5.49
HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature (1988) 5.45
Cancer registration: principles and methods. Statistical methods for registries. IARC Sci Publ (1991) 5.44
Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo. J Exp Med (1998) 5.33
A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody. Eur J Immunol (1979) 5.17
Potential impact of global climate change on malaria risk. Environ Health Perspect (1995) 4.44
Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells. Cell (1984) 3.97
Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat Med (1996) 3.94
Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol (1999) 3.79
Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer (2000) 3.79
Excess mortality in England and Wales, and in Greater London, during the 1995 heatwave. J Epidemiol Community Health (1998) 3.67
Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest (1998) 3.53
A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J Immunol (1999) 3.36
Deviation from prescribed drug treatment after discharge from hospital. Br Med J (1976) 3.35
Estimates of the worldwide frequency of twelve major cancers. Bull World Health Organ (1984) 3.32
Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer (2011) 3.23
Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science (2000) 3.20
Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer (2002) 3.17
Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer (1993) 3.13
A human lymphocyte-associated antigen involved in cell-mediated lympholysis. Eur J Immunol (1983) 3.08
Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. AIDS Res Hum Retroviruses (1996) 3.01
Cancer Incidence in Five Continents. Comparability and quality of data. IARC Sci Publ (1992) 2.99
A case-control study of cervical cancer screening in north east Scotland. Br Med J (Clin Res Ed) (1985) 2.98
Ecological study of reasons for sharp decline in mortality from ischaemic heart disease in Poland since 1991. BMJ (1998) 2.94
Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc Natl Acad Sci U S A (1991) 2.90
HLA restriction of cell-mediated lysis of influenza virus-infected human cells. Nature (1977) 2.88
The impact of screening on the incidence of cervical cancer in England and Wales. Br J Obstet Gynaecol (1985) 2.83
Cytotoxic T-cell recognition of HIV proteins and peptides. AIDS (1991) 2.83
A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. AIDS (1999) 2.75
High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. Int Immunol (1990) 2.71
Early effects of climate change: do they include changes in vector-borne disease? Philos Trans R Soc Lond B Biol Sci (2001) 2.71
HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi. J Immunol (2000) 2.69
Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer (1997) 2.65
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology (1999) 2.62
Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS. Int J Cancer (1993) 2.58
A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17. Hum Immunol (1980) 2.56
Strategies for global control of cervical cancer. Int J Cancer (1995) 2.52
Misconceptions about the use of genetic tests in populations. Lancet (2001) 2.48
Environment and health: 2. Global climate change and health. CMAJ (2000) 2.45
Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. Nature (1997) 2.41
Influenza virus-specific cytotoxic T cells in man; induction and properties of the cytotoxic cell. Eur J Immunol (1978) 2.39
Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev (1997) 2.36
[Esophageal cancer in Ille-et-Vilaine in relation to levels of alcohol and tobacco consumption. Risks are multiplying]. Bull Cancer (1977) 2.34
Declining T-cell immunity to influenza, 1977-82. Lancet (1983) 2.34
An epidemiologic study of mortality within a cohort of rubber workers, 1964-72. J Occup Med (1974) 2.33
Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc Natl Acad Sci U S A (1995) 2.30
Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer (2004) 2.30
Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen. J Immunol (2000) 2.29
Mortality among rubber workers: Relationship to specific jobs. J Occup Med (1976) 2.27
The Danish case-control study of cutaneous malignant melanoma. II. Importance of UV-light exposure. Int J Cancer (1988) 2.26
CD8(+) T-cell selection, function, and death in the primary immune response in vivo. J Clin Invest (2000) 2.19
The epidemiology of conjunctival squamous cell carcinoma in Uganda. Br J Cancer (2002) 2.18
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst (1980) 2.17
Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. J Gen Virol (1986) 2.16
Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer (2003) 2.14
Oligoclonal expansions of CD8(+) T cells in chronic HIV infection are antigen specific. J Exp Med (1998) 2.13
Assessing ecosystem health. Trends Ecol Evol (1998) 2.11
HLA B37 determines an influenza A virus nucleoprotein epitope recognized by cytotoxic T lymphocytes. J Exp Med (1986) 2.09
Trends in malignant melanoma of the skin. World Health Stat Q (1980) 2.09
Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer. Int J Cancer (1985) 2.08
Screening for liver cancer: results of a randomised controlled trial in Qidong, China. J Med Screen (2003) 2.07
Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology (2011) 2.04
An evaluation of screening policies for cervical cancer in England and Wales using a computer simulation model. J Epidemiol Community Health (1986) 2.02
Cancer incidence in Blantyre, Malawi 1994-1998. Trop Med Int Health (2001) 2.01
Solvent exposure and leukemia among rubber workers: an epidemiologic study. J Occup Med (1975) 2.00
How successful is screening for congenital disease of the hip? Am J Public Health (1981) 1.97
Increased frequency of HLA-Cw3 and HLA-Dw4 in rheumatoid arthritis. Arthritis Rheum (1977) 1.95
Declining blood lead levels and changes in cognitive function during childhood: the Port Pirie Cohort Study. JAMA (1998) 1.95
The management of hypertension--a study of records in general practice. J R Coll Gen Pract (1979) 1.95
Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection. AIDS (2000) 1.92
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol (2007) 1.92
Effectiveness of neonatal screening for congenital dislocation of the hip. Lancet (1978) 1.92
The Port Pirie cohort study: maternal blood lead and pregnancy outcome. J Epidemiol Community Health (1986) 1.89
Geographic and ethnic variations in the incidence of childhood cancer. Br Med Bull (1996) 1.87
Does breastfeeding at six months predict cognitive development? Aust N Z J Public Health (1998) 1.87
HLA class I typing by PCR: HLA-B27 and an African B27 subtype. Lancet (1991) 1.86
Patterns of cigarette sales and lung cancer mortality in some central and eastern European countries, 1960-1989. Cancer (1995) 1.86
Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses. J Clin Invest (2001) 1.85
Short-term associations between outdoor air pollution and mortality in London 1992-4. Occup Environ Med (1999) 1.85
An overview of cancer survival in developing countries. IARC Sci Publ (1998) 1.84
BirA enzyme: production and application in the study of membrane receptor-ligand interactions by site-specific biotinylation. Anal Biochem (1999) 1.81